Guggenheim Capital LLC Ptc Therapeutics, Inc. Call Options Transaction History
Guggenheim Capital LLC
- $12 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
256Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$454 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$384 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$366 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$315 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$237 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.54B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...